References

Pathogenicity and virulence of Staphylococcus aureus

10.1080/21505594.2021.1878688 · 2021 · External reference

Adipocytes armed against Staphylococcus aureus

10.1056/nejmcibr1500271 · 2015 · External reference

The incidence of skin and soft tissue infections in the United States and associated healthcare utilization between 2010 and 2020

10.1093/ofid/ofae267 · 2024 · External reference

Trends and risk factors in the antibiotic management of skin and soft tissue infections in the United States

10.1080/09546634.2020.1859442 · 2022 · External reference

Clinical impact of Staphylococcus aureus skin and soft tissue infections

10.3390/antibiotics12030557 · 2023 · External reference

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

10.1016/s0140-6736(21)02724-0 · 2022 · External reference

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

10.1016/s0140-6736(24)01867-1 · 2024 · External reference

Prevention of Staphylococcus aureus infections through vaccination: state of affairs

10.1016/s2213-7165(22)00276-4 · 2022 · External reference

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial

10.1001/jama.2013.3010 · 2013 · External reference

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis

10.1056/nejmoa011297 · 2002 · External reference

Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: phase III randomized study

10.4161/hv.34414 · 2015 · External reference

Efficacy of a 4-antigen Staphylococcus aureus vaccine in spinal surgery: the STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) randomized clinical trial

10.1093/cid/ciad218 · 2023 · External reference

Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors

10.4161/hv.34407 · 2014 · External reference

Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: a phase 2 vaccine trial among US Army infantry trainees

10.1016/j.vaccine.2021.04.031 · 2021 · External reference

Staphylococcus aureus vaccine research and development: the past, present and future, including novel therapeutic strategies

10.3389/fimmu.2021.705360 · 2021 · External reference

The candidate antigens to achieving an effective vaccine against Staphylococcus aureus

10.3390/vaccines10020199 · 2022 · External reference

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

10.1080/14760584.2016.1213632 · 2017 · External reference

Notes on the treatment of furunculosis, sycosis, and acne by the inoculation of a Staphylococcus vaccine

10.1016/s0140-6736(01)83603-5 · 1902 · External reference

Staphylococcus aureus clumping factor A remains a viable vaccine target for prevention of S. aureus infection

10.1128/mbio.00225-16 · 2016 · External reference

Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections

10.1016/j.vaccine.2016.09.061 · 2016 · External reference

Efficacy of active immunization with attenuated α-hemolysin and panton-valentine leukocidin in a rabbit model of Staphylococcus aureus necrotizing pneumonia

10.1093/infdis/jiz437 · 2020 · External reference

Vaccination with staphylococcal protein A protects mice against systemic complications of skin infection recurrences

10.3389/fimmu.2024.1355764 · 2024 · External reference

Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection

10.1080/21645515.2017.1304334 · 2017 · External reference

Linking S. aureus immune evasion mechanisms to staphylococcal vaccine failures

10.3390/antibiotics13050410 · 2024 · External reference

Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine

10.1016/j.chom.2022.06.006 · 2022 · External reference

Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy

10.1038/s41541-022-00598-3 · 2023 · External reference

Staphylococcus aureus skin and soft tissue infection recurrence rates in outpatients: a retrospective database study at 3 US medical centers

10.1093/cid/ciaa1717 · 2021 · External reference

Development of a Staphylococcus aureus vaccine: an ongoing journey

10.1093/cid/ciad217 · 2023 · External reference

Original antigenic sin: a comprehensive review

10.1016/j.jaut.2017.04.008 · 2017 · External reference

A path forward for Staphylococcus aureus vaccine development

10.1084/jem.20240002 · 2024 · External reference

To err is human, to forgive may require different vaccines

10.1016/j.chom.2022.07.005 · 2022 · External reference

Staphylococcus aureus pathogenesis in diverse host environments

10.1093/femspd/ftx005 · 2017 · External reference

Immune control of Staphylococcus aureus—regulation and counter-regulation of the adaptive immune response

10.1016/j.ijmm.2013.11.008 · 2014 · External reference